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Expression of senescence-related genes in human corneal
endothelial cells
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Purpose: To investigate the expression of p16INK4a, p21WAF1/CIP1, p27KIP1, and p53 in human corneal endothelial cell
(HCEC) senescence ex vivo at various donor ages.
Methods: Residual corneal tissues obtained after penetrating keratoplasty were used in this study. Age, death-to-
preservation interval, and preservation-to-surgery interval of the donors were recorded. Corneal endothelial cell survival
and density were evaluated by trypan blue and alizarin red staining immediately after keratoplasty. Fresh frozen sections
of donor corneas at various ages (18, 33, 54, and 68 years) were immunostained in situ. Total RNA extracted from age
groups of 20, 30, 40, 50, and 60 years was evaluated by reverse-transcriptase polymerase chain reaction (PCR) to reveal
the expression of the senescence-related genes, p16INK4a, p21WAF1/CIP1, p27KIP1, and p53, in HCECs. Total RNA extracted
from 20-, 24-, 26-, 30-, 50-, 55-, 56-, and 60-year-old donor groups was subjected to real-time PCR analysis for
measurement of gene expression. The results of the young (≤30 years) and the old (≥ 50 years) were compared by the
unpaired t-test. Ex vivo senescence of HCECs from the donors at various ages (9, 17, 23, 57, 65, and 67 years) was
observed by senescence-associated β-galactosidase activity (SA-β-Gal) staining at pH 6.0.
Results: The mean endothelial cell density of the donor corneas was 2,391.4±84.6 cells/mm2, and the survival rate of the
endothelial cells was 84.4%±5.3%. Hematoxylin and eosin staining showed normal structures of the corneal epithelium,
stroma, and endothelium. The expression and nuclear localization of p16INK4a, p21WAF1/CIP1, p27KIP1, and p53 in HCECs
were confirmed by immunohistochemistry in situ. Reverse transcriptase PCR examination showed positive target bands
of each gene at each age group. An age-related increase in p16INK4a expression was observed by real-time PCR (p=0.014).
There was no significant difference in the expression levels of p21WAF1/CIP1, p27KIP1, and p53 between the young and old
donors (p=0.875, 0.472, and 0.430, respectively). Strong SA-β-Gal activity was observed in the endothelial cells of the
old donors while there was weak and little-to-no blue staining in the endothelia from the young.
Conclusions: The population of HCECs exhibiting senescence-like characteristics increases with age. p16INK4a, p21WAF1/
CIP1, p27KIP1, and p53 are expressed in HCECs despite donor ages. The p16INK4a signal pathway might play a key role in
the process of senescence in HCECs.
The corneal endothelium is a single layer of cells located
at the posterior of the cornea. It is responsible for maintaining
corneal  transparency  through  its  barrier  and  ionic  pump
function.  Human  corneal  endothelial  cells  (HCECs)  are
considered to be nonproliferative in vivo, and therefore, a
corneal  endothelial  wound  heals  predominantly  by  cell
migration and enlargement [1-3]. It is clear that HCECs do
retain proliferative capacity in vivo [4-6]. However, up to
now, methods to induce proliferation in cultured HCECs, such
as  viral  oncogene  transformation  [7]  and  growth  factor
supplement [8], cannot be used in clinical practice. As a result
of excessive cell loss due to accidental or surgical trauma or
disease, corneal endothelial dysfunction may lead to corneal
edema and vision loss, requiring corneal transplantation to
restore normal vision. However, graft endothelial cell density
(ECD) even without a rejection episode continues to decrease
at  a  rapid  rate  compared  to  normal  eyes  [9,10].
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Correspondingly, late endothelial failure [9,10] and chronic
corneal allograft dysfunction (CCAD) [11] may occur, which
has become a major cause of late transplant failure [10,12].
Some studies have reported that the deterioration in organ
function might be related with the senescence of key cells
within that tissue, and the chronic transplant dysfunction was
considered to be caused by accelerated aging [13-15]. Is it
accelerated senescence of HCECs resulting from trauma or
disease  that  contributes  to  the  dysfunction  of  corneal
endothelial  cells?  An  investigation  on  the  senescence  of
normal HCECs is required first.
Cellular senescence is a program activated by normal
cells in response to a variety of stresses. Many studies have
reported the importance of senescence-related genes such as
p16INK4a, p21WAF1/CIP1, p27KIP1, and p53 in cellular senescence.
p16INK4a, p21WAF1/CIP1, and p27KIP1 are cyclin-dependent kinase
inhibitors (CDKI), which are negative regulators of the cell
cycle. They can inhibit the cell cycle progression and maintain
the G1 phase arrest of cells [16]. Their accumulation in aged
cells of some types was also reported [17,18]. p53 functions
as a central integration point for various signaling pathways
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161of senescence and inhibits cell division primarily through a
p21WAF1/CIP1 pathway. Inactivation of p53 may prevent or delay
the onset of senescence. p53 could not only downregulate cell
division  during  the  normal  process  of  aging  but  also  get
involved  in  a  response  to  telomere  shortening  [19,20],
oxidative  stress,  and  DNA  damage  [21,22].  A  different
signaling pathway may be activated in different species or by
various types of stresses. It was reported that p16INK4a, p21WAF1/
CIP1, p27KIP1, and p53 are all expressed in corneal endothelial
cells of several species [23-25]. Their different age-related
expressions in cultured HCECs might contribute to the age-
related  difference  in  the  proliferative  capacity  [5,26].
However, development of aging in HCECs in vivo has not yet
been  proven  because  of  the  influence  of  the  culture
environment and passage stress. Obviously, the role of HCEC
senescence in different clinical problems cannot be elucidated
without an evaluation on the mechanisms of HCEC aging in
vivo. To investigate the key effectors in the mechanism of
HCEC  senescence  in  vivo,  the  relative  expression  of
senescence-related genes was analyzed in HCEC ex vivo at
various donor ages in this study.
METHODS
Human corneal tissues and evaluation: Corneal rims, residual
parts dissected from donor corneas by a circular trephine in
penetrating keratoplasty, were immediately collected for this
study. One quarter of each corneal rim was cut and stained
with trypan blue and alizarin red [27]. Donor corneal rims with
an ECD of < 2000 cells/mm2 or an endothelial cell survival
rate  of  <  80%  were  excluded  [28].  Additional  exclusion
criteria were similar to those previously indicated [29]. Some
corneal rim tissues were placed with the endothelium side up
on a Teflon block and cut with a circular trephine of 10–11
mm in diameter within the Schwalbe’s line under a surgical
microscope. Descemet’s membrane with endothelium was
easily detached from the underlying stroma with forceps and
stripped away intact. The stripped endothelial tissues were
frozen at −80 °C for RNA analysis. Some corneal rims were
sectioned  and  frozen  in  optimum  cutting  temperature
compound (Tissue-Tek, Tokyo, Japan) and stored at −80 °C
until ready for cryostat sectioning.
Before surgery, the human donor corneas were provided
by the Shandong Eye Institute Eye Bank (Qingdao, China)
and preserved in DX intermediate-term medium at 4 °C [30].
Most of the donors suffered from sudden death. The death-to-
preservation  interval  (<  20  h)  and  preservation-to-surgery
interval (< 4 days) were recorded. The handling of the donor
tissues adhered to the tenets of the Declaration of Helsinki of
1975 and its 1983 revision in protecting donor confidentiality.
Qualitative  immunohistochemical  detection:  Streptavidin-
biotin complex (SABC) immunohistochemical stainings of
p16INK4a,  p21WAF1/CIP1,  p27KIP1,  and  p53  were  qualitatively
detected in sections of four corneal samples (18, 33, 54, and
68 years). Transverse corneal sections (6 μm) were put on
slides and air dried. Slides were fixed in acetone at −20 °C for
10 min and washed in PBS (pH 7.4). Endogenous peroxidase
activity  was  reduced  in  the  section  by  an  incubation  in
methanol with 0.6% hydrogen peroxide for 30 min. Sections
were incubated with 5% BSA supplied in an instant-type
SABC  immunohistochemistry  kit  (Boster  Corp,  Wuhan,
China) for 20 min then with rabbit polyclonal anti-p16, mouse
monoclonal anti-p21, mouse monoclonal anti-p27, or rabbit
monoclonal anti-p53 antibodies (1:50, 1:100, 1:50, and 1:25,
respectively;  Lab  Vision  Corp,  Fremont,  CA)  diluted  in
antibody dilution buffer (Boster Corp) overnight at 4 °C. After
the PBS washing, biotin-conjugated anti-mouse or anti-rabbit
immunoglobulin G, depending on the primary antibody, was
used as a secondary antibody at 37 °C for 20 min. The sections
were then washed with PBS and treated with SABC solution
at 37 °C for 20 min. Peroxidase activity was detected with the
substrate diaminobenzidine (DAB kit; Boster Corp). Negative
controls for all antigens consisted of tissue sections incubated
with PBS instead of a primary antibody. The slides were
treated with graded alcohols and xylene and mounted with
DPX  (distyrene,  plasticizer,  and  xylene;  BDH,  Poole,
England). Permanent slides were covered with a 1.5-mm thick
cover slip, examined using a light microscope (Eclipse e800;
Nikon, Tokyo, Japan), and photographed with a Nikon digital
camera DXM 1200.
Qualitative reverse transcriptase-polymerase chain reaction
examination: Samples of HCEC tissue from donors of various
ages were divided into groups of 20, 30, 40, 50, and 60 years.
Three to four corneal rims of similar age were included in each
group. Total RNA was isolated from HCECs of each group
using the RNeasy Mini kit (Qiagen GmbH, Hilden, Germany)
according to the manufacturer’s protocol. The polymerase
chain reaction (PCR) primers were designed on the basis of
the  published  human  gene  sequences  (Table  1).  Reverse-
transcriptase PCR (RT–PCR) was performed to evaluate the
expression of these genes in HCECs using the housekeeping
gene, GAPDH, as an internal control. In brief, the first-strand
TABLE 1. PRIMERS USED FOR REVERSE-TRANSCRIPTASE POLYMERASE CHAIN REACTION
Gene name Primer sequence Product length
p16INK4a F: GAC ATC CCC GAT TGA AAG AA 198 bp
R: TTT ACG GTA GTG GGG GAA GG
p21WAF1/CIP1 F: GAC ACC ACT GGA GGG TGA CT 172 bp
R: CAG GTC CAC ATG GTC TTC CT
p27KIP1 F: TCT ACT GCG TGG CTT GTC AG 240 bp
R: CTG TAT TTG GAG GCA CAG CA
p53 F: GGC CCA CTT CAC CGT ACT AA 156 bp
R: GTG GTT TCA AGG CCA GAT GT
GAPDH F: ACC ACA GTC CAT GCC ATC AC 439 bp
R: TCC ACC ACC CTG TTG CTG TA
Primers  are  used  to  detect  genes  from  mRNA  in  human
corneal endothelial cells at various ages. The sequence for
design of forward and reverse primers and the number of base
pairs  in  expected  polymerase  chain  reaction  product  are
shown.
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162cDNA was synthesized from equal amounts of total RNA
(300–500 ng/μl) using a cDNA synthesis kit (BBI, Toronto,
Canada)  according  to  the  manufacturer’s  protocol.  PCR
amplification  was  performed  (Mastercycler  gradient;
Eppendorf, Köln, Germany) using the following program:
denaturation at 95 °C for 2 min followed by 35 cycles of
denaturation at 95 °C for 1 min, annealing at 60 °C for 30 s,
and extension at 72 °C for 1 min followed by a last extension
at  72  °C  for  10  min.  The  negative  controls  consisted  of
omission of RNA or reverse transcriptase from the reaction
mixture. An aliquot of the PCR product was electrophoresed
on 1.5% agarose gels and stained with ethidium bromide for
40  min.  Photographs  of  the  gel  were  taken  with  a  high-
resolution camera. The density of the bands was analyzed on
the  gel  using  ultraviolet  (UV)  illumination  and  Image  J
analysis software.
Fluorescent  real-time  quantitative  polymerase  chain
reaction: Samples were divided into age groups of 20, 24, 26,
30, 50, 55, 56, and 60 years. Three to four corneal rims of
similar age (within two years) were included in each group.
For the pooled donors, the average age was determined. The
same  procedures  of  total  RNA  extraction  and  first-strand
cDNA  synthesis  were  performed  as  mentioned  above.
Taqman reagents and the ABI Prism 7500 System were used
in  real-time  PCR  as  recommended  by  the  manufacturer
(Applied Biosystems, Foster City, CA). Each sample was
assayed in duplicate with Taqman Universal PCR Master Mix
(Applied Biosystems). Primers and oligonucleotide probes
used are listed in Table 2. The cycling conditions were as
follows: 10 min at 95 °C and 40 cycles of amplification for 15
s at 95 °C and 1 min at 60 °C. The expected fragment length
was between 150 and 300 bp. The quantification data were
analyzed  with  the  SDS  System  Software  (7500  System;
Applied Biosystems). After PCR baseline subtraction was
performed  by  the  software,  the  log-linear  portion  of  the
fluorescence versus cycle plot was extended to determine a
fractional cycle number at which a threshold fluorescence was
obtained (threshold cycle, Ct) as a reference for each analyzed
gene and GAPDH. The comparative Ct method was used for
quantification of the target genes relative to GAPDH. The 20-
year-old group was used as a calibrator, and the data were
presented as the fold change in gene expression relative to the
calibrator. The difference in the means between the young
(≤ 30 years) and old groups (≥ 50 years) was calculated with
an unpaired t-test (SPSS software version 12.0; SPSS Inc.,
Chicago, IL). A p<0.05 was considered to be significant.
Senescence-associated  β-galactosidase  activity  staining:
According to previous reports [29,31], corneal rims obtained
from six donors (9, 17, 23, 57, 65, and 67 years) were washed
with  PBS  and  fixed  with  4%  formaldehyde  at  room
temperature for 15 min. After the wash with PBS (pH 6.0),
the tissues were incubated at 37 °C overnight in a humidified
chamber with freshly prepared SA-β-Gal staining solution
(1 mg/ml X-Gal in dimethylformamide, 40 mmol/l citric acid
and  phosphate  buffer,  pH  6.0,  5  mmol/l  potassium
ferrocyanide, 5 mmol/l potassium ferricyanide, 150 mmol/l
sodium chloride, and 2 mmol/l magnesium chloride). The
positive control for this assay consisted of incubating corneal
rims in staining solution adjusted to pH 4.0 as required for
lysosomal β-galactosidase staining. On the following day,
tissues were washed twice in PBS at room temperature for 10
min,  and  staining  was  visualized  and  captured  using  a
TABLE 2. PRIMERS AND PROBES USED FOR FLUORESCENT REAL-TIME QUANTITATIVE POLYMERASE CHAIN REACTION
Gene name Primer sequence(5′→3′)
p16INK4a F: AAG GTC CCT CAG ACA TCC C
R: TGT AGG ACC TTC GGT GAC TG
PROBE: FAM-TCC GGA GGT TTC TCA GAG CCT CTC-TAMRA
p21WAF1/CIP1 F: CAG ACC AGC ATG ACA GAT TTC
R: TTA GGG CTT CCT CTT GGA GA
PROBE: ACC ACT CCA AAC GCC GGC TG
p27KIP1 F: CCT CCT CCA AGA CAA ACA GC
R: CAT TCA GAG CGG GAT TAT CTT T
PROBE: FAM-TCG AGT TCC TGA CAA GCC ACG C-TAMRA
p53 F: AAC AAC ACC AGC TCC TCT CC
R: CTC ATT CAG CTC TCG GAA CA
PROBE: FAM-CCC TTC AGA TCC GTG GGC GT-TAMRA
GAPDH F: ATG CTG GCG CTG AGT ACG T
R: AGC CCC AGC CTT CTC CAT
PROBE: FAM-TGG AGT CCA CTG GCG TCT TCA-TAMRA
Fluorescent real-time quantitative polymerase chain reaction is performed as specified in the Methods section. Sequence specific
primers and probes for p16INK4a, p21WAF1/CIP1, p27KIP1, and p53 are listed.
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163microscope equipped with a digital camera (Eclipse e800;
Nikon).
RESULTS
Qualitative  examination  of  senescence-related  genes  in
human  corneal  endothelial  cells:  Positive  staining  for
p16INK4a, p21WAF1/CIP1, p27KIP1, and p53 were found and showed
a similar nuclear localization in HCECs. Figure 1 presents
representative  micrographs  of  the  immunohistochemical
staining in situ of freshly frozen corneal sections. The analysis
of mRNA from HCECs by RT–PCR indicated that p16INK4a,
p21WAF1/CIP1,  p27KIP1,  and  p53  transcripts  were  present  at
various donor ages. No band was seen in the controls without
RNA or reverse transcriptase (Figure 2).
Quantitative analysis of relative expression of senescence-
related genes in human corneal endothelial cells: Total RNA
extracted from HCECs of the eight age groups was subjected
to  quantitative  real-time  PCR  for  p16INK4a,  p21WAF1/CIP1,
p27KIP1, and p53. Figure 3 shows the expression of p16INK4a
normalized to GAPDH RNA and the fold change in gene
expression related to the calibrator of the 20-year-old group.
There  was  a  statistically  significant  difference  in  p16INK4a
expression between the young (≤ 30 years) and old groups
(≥ 50 years; p=0.014). Relative gene expression quantitation
and  fold  change  from  the  eight  groups  with  p21WAF1/CIP1,
p27KIP1,  and  p53  were  shown  in  Figure  4,  5,  and  6,
Figure 1. Immunohistochemical staining of p16INK4a, p21WAF1/CIP1,
p27KIP1, and p53. Representative fresh-frozen sections of human
corneas from donors at various ages (A: p16, 18 years; B: p21, 33
years; C: p27, 54 years; D: p53, 18 years; E: control, 68 years) are
shown. Positive staining for all four senescence-related genes are
clearly visible in the endothelial nuclei. Magnification; 400×.
respectively. There was no significant difference in p21WAF1/
CIP1, p27KIP1, and p53 expression between any two age groups
(p=0.875, 0.472, 0.430, respectively). HCECs from the old
donors expressed significantly higher levels of p16INK4a than
cells from young donors. In contrast, there were no obvious
changes in the expression of p21WAF1/CIP1, p27KIP1, and p53 with
age.
Evaluation of senescence-associated β-galactosidase activity
in  human  corneal  endothelial  cells:  SA-β-Gal  has  been
recommended as an indicator of cell senescence in vitro [32]
and in vivo [33]. We assessed SA-β-Gal staining for HCECs
of different ages. As shown in Figure 7A, there was weak blue
staining for SA-β-Gal activity in HCECs from the young
donors.  On  the  contrary,  a  much  more  focal  and  even
multifocal intense staining for SA-β-Gal activity was detected
in HCECs from the old donors (Figure 7B). There was an
increase  in  the  number  of  HCECs  that  exhibited
characteristics  of  senescence  from  the  old  donors.  The
positive staining was confirmed by normal β-galactosidase
staining at pH 4.0 in all cells.
DISCUSSION
Penetrating  keratoplasty  remains  a  major  choice  in  the
treatment  of  corneal  endothelial  dysfunction.  However,
besides the lack of donors, poor quality of the donor corneas
with low cell density brings limits to the surgical involvement.
Moreover,  corneal  grafts  may  lose  endothelial  cells  at  an
accelerated rate compared with healthy corneas [9,10]. This
Figure  2.  Detection  of  p16INK4a,  p21WAF1/CIP1,  p27KIP1,  and  p53
mRNA. Electrophoretic gels show the presence of mRNA for the
four senescence-related genes. Lane 1 to Lane 5 shows HCECs of
the 20-, 30-, 40-, 50-, and 60-year-old groups, respectively. Lane 6
is the negative control. Lane M is Marker DL 2000. All bands migrate
to their expected product length as summarized in Table 1.
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164loss eventually leads to late endothelial failure of the corneal
graft, which is the major overall reason for graft failure [10,
12].  ECD  is  a  common  core  factor  related  to  corneal
endothelial  cell  diseases,  donor  cornea  quality,  and  graft
prognosis. The deterioration of organ or graft function was
considered to be the result of accelerated senescence of key
cells within that tissue [13-15]. Therefore, we can suppose the
importance of senescence of corneal endothelium on ECD.
Among the morphological characteristics of senescent
cells  are  cell  enlargement,  increased  vacuolation,  and  the
Figure 3. Quantitative real-time polymerase chain reaction analyses
of p16INK4a mRNA expression in human corneal endothelial cells at
various ages. Total RNA was isolated from HCECs of each group,
and the first-strand cDNA were aynthesized from equal amounts of
total RNA. Quantitative real-time PCR was performed to analyze
p16INK4a mRNA expression. A shows the expression of p16INK4a from
the eight age groups normalized to GAPDH mRNA. B demonstrates
fold change in p16INK4a expression relative to the calibrator of the 20-
year-old  group.  C  is  the  comparison  of  the  average  level  of
p16INK4a mRNA expressed in HCECs between the young (≤ 30 years)
and old (≥ 50 years) donors. Data are presented as mean±standard
deviation, and a p<0.05 is considered to be statistically significant.
Results indicate a significant increase (p=0.014) in p16INK4a mRNA
expression in HCECs from the old donors.
presence  of  lipofuscin.  Cells  also  exhibit  proliferative
changes, including presence of multiple nuclei and/or greater
than 2N DNA, a decreased response to mitogens, decreased
telomere  length,  an  increase  in  expression  of  the  tumor
suppressor,  p53,  and  suppression  of  CDKI  genes.  These
morphological and proliferative characteristics of senescent
cells can be observed in HCECs at aging [34-36] or damage
Figure 4. Quantitative real-time polymerase chain reaction analyses
of p21WAF1/CIP1 mRNA expression in human corneal endothelial cells
at various ages. Total RNA was isolated from HCECs of each group,
and the first-strand cDNA were aynthesized from equal amounts of
total RNA. Quantitative real-time PCR was performed to analyze
p21WAF1/CIP1 mRNA expression. A shows the expression of p21WAF1/
CIP1 from the eight age groups normalized to GAPDH mRNA. B
demonstrates fold change in p21WAF1/CIP1 expression relative to the
calibrator  of  the  20-year-old  group.  C  is  the  comparison  of  the
average level of p21WAF1/CIP1 mRNA expressed in HCECs between
the young (≤ 30 years) and old (≥ 50 years) donors. Data are presented
as  mean±standard  deviation  and  a  p<0.05  is  considered  to  be
statistically  significant.  Results  indicate  no  significant  increase
(p=0.875) in p21WAF1/CIP1 mRNA expression in HCECs from the old
donors.
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165[36],  after  transplantation  [37],  or  when  cultured  in  vitro
[15], which may support the likelihood of HCEC senescence.
Although HCECs have long telomeres throughout life [38],
the process of cell senescence is very complex and most likely
determined  by  three  interdependent  or  convergent
mechanisms  [39,40]:  the  intracellular  biological  clock—
telomeres,  genetic  mechanisms  of  regulation,  and  the
influence of various environmental stress factors.
Figure 5. Quantitative real-time polymerase chain reaction analyses
of p27KIP1 mRNA expression in human corneal endothelial cells at
various ages. Total RNA was isolated from HCECs of each group,
and the first-strand cDNA were aynthesized from equal amounts of
total RNA. Quantitative real-time PCR was performed to analyze
p27KIP1 mRNA expression. A shows the expression of p27KIP1 from
the eight age groups normalized to GAPDH mRNA. B demonstrates
fold change in p27KIP1 expression relative to the calibrator of the 20-
year-old group. C is the comparison of the average level of p27KIP1
mRNA expressed in HCECs between the young (≤ 30 years) and old
(≥ 50 years) donors. Data are presented as mean±standard deviation,
and a p<0.05 is considered to be statistically significant. Results
indicate  no  significant  increase  (p=0.472)  in  p27KIP1  mRNA
expression in HCECs from the old donors.
Neutral (pH 6.0) β-galactosidase, termed SA-β-Gal, is
widely used in the identification of the presence of senescent
cells in vitro [32] and in vivo [33]. Its frequency has been
shown to rise with the increasing age of several tissues from
humans and rodents. Mishima et al. [31] first applied SA-β-
Gal staining to eye research. Recently, it was used in detecting
the characteristics of HCEC senescence by Mimura and Joyce
[29]. In this confirmative study, there was little to no staining
for SA-β-Gal in HCECs from the young donors but relatively
Figure 6. Quantitative real-time polymerase chain reaction analyses
of  p53  mRNA  expression  in  human  corneal  endothelial  cells  at
various ages. Total RNA was isolated from HCECs of each group,
and the first-strand cDNA were aynthesized from equal amounts of
total RNA. Quantitative real-time PCR was performed to analyze
p53 mRNA expression. A shows the expression of p53 from the eight
age groups normalized to GAPDH mRNA. B demonstrates fold
change in p53 expression relative to the calibrator of the 20-year-old
group. C is the comparison of the average level of p53 mRNA
expressed in HCECs between the young (≤ 30 years) and old (≥ 50
years). Data are presented as mean±standard deviation, and a p<0.05
is  considered  to  be  statistically  significant.  Results  indicate  no
significant increase (p=0.430) in p53 mRNA expression in HCECs
from the old donors.
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166more intense and greater staining from the old. It proves that
senescent HCECs accumulate SA-β-Gal with age in vivo and
confirms what Mimura and Joyce found [29].
There were few reports on the importance of CDKI genes
in senescence of HCECs in vitro. The role of cell senescence
in  clinical  eye  problems,  such  as  late  endothelial  failure,
cannot be elucidated without an evaluation on the mechanism
of HCECs aging in vivo. Primary culture cells are considered
to possess similar biological characters with those in vivo.
However,  the  expression  of  CDKI  in  HCECs  may  be
influenced by cell replication in the culture microenvironment
in vitro. The only evaluation of CDKI genes in HCECs in vivo
was made by immunohistochemistry in previous reports [23,
24,26]  and  confirmed  in  the  current  study.  It  might  be
attributable to the limited HCECs in a single layer and limited
number of donors. The residual part of corneal grafts after
keratoplasty  was  collected  over  time,  which  assured  the
normality and number of endothelial tissues in some degree.
Three to four corneas at similar ages were contained in each
sample for RNA analysis in the present study, and a similar
method was adapted in other experiments [41,42]. Although
the characteristics of age-related decrease in ECD of rodents
are observed to be similar [43,44], there are species-related
differences in endothelial proliferative activity [23,45]. In
addition, the major signaling pathway of cell senescence may
differ  among  species,  and  the  p16INK4a  mediated  pathway
appears to be more active in human beings [14]. All of the
above indicates that the senescence mechanism of HCECs can
not be deduced from the related studies in animals.
Senescence-related gene expression in HCECs ex vivo
from the young and old donors was compared in this study.
Immunohistochemistry and RT–PCR examinations confirm
the expression of p16INK4a, p21WAF1/CIP1, p27KIP1, and p53 in
HCECs. There was an increase in the mRNA expression level
of p16INK4a in the old donors by quantitative real-time PCR
whereas the levels of p21WAF1/CIP1, p27KIP1, and p53 remained
steady. An age-related increase in p16INK4a expression was also
observed in other cell types in vivo [13] and HCECs cultured
in vitro [26]. This reflects the stability of p16INK4a mRNA,
which may be involved in the long-term cell cycle regulation.
The  p16INK4a  mediated  signaling  pathway  might  play  an
important role in HCEC aging. The age-related difference in
Figure  7.  Senescence-associated  β-
galactosidase  activity  stainings  in
human corneal endothelial cells of ex
vivo corneas from the young and old
donors. In column A, there are weak and
few to no stainings for SA-β-Gal activity
in the young donor. In column B, more
focal  weak  and  multifocal  intense
stainings for SA-β-Gal are detected in
the old donors. Magnification; 200×.
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167p16INK4a expression may be used as an indicator for accelerated
senescence of HCECs. As in other cell types [13], increased
expression of CDKI genes was found with increasing age in
the  tubules  of  the  kidney  cortex.  There  were  substantial
differences between chronological and computed biological
ages of the grafts, which showed an acceleration of senescence
caused by the influence of various stresses in chronic allograft
nephrology.
In the in vitro study, western-blot analysis showed that
p16INK4a and p21WAF1/CIP1 levels increased with donor ages in
primary cultures of HCECs, but p27KIP1 levels did not have
such an increase. However, p27KIP1 levels were significantly
lower in the passage-4 HCECs from the older donors [26]. In
the present study, the expression levels of p21WAF1/CIP1 and
p27KIP1 genes did not differ with donor ages in the HCECs of
ex vivo corneas. The results may reflect a difference in cellular
response to stresses from the culture microenvironment rather
than  to  an  intrinsic  age-related  difference  in  p21WAF1/CIP1
expression.  Moreover,  the  p27KIP1  expression  level  was
considered to be different with multiple passaging for the
difference between primary culture cells and passage 4 cells
[26]. However, it is important to note that p27KIP1 protein
expression is not solely dependent on its mRNA level but also
regulated posttranslationally [46] although similar results can
be observed ex vivo and in primary cultured HCECs. The
mRNA level of the 30-year-old donors showed a significant
increase among the eight age groups, which appeared to be an
“outlier” (Figure 4). But for the same sample, the mRNA
relative levels among the other groups were not consistent
among the four genes. Such a difference might be attributed
to the variation among samples. Similarly, there is at least a
three-fold increase in p27 mRNA in the 26-year-old group
(Figure 5). Enlargement of the sample size might decrease the
variation.
In this study, the p53 expression level was not detected
to be different between the young and old groups. Genes for
some cell cycle control proteins such as p53 are located close
to  the  telomeres  [47,48],  and  their  expressions  may  be
influenced by telomere length [19,20]. There was a correlation
between the decreasing telomere length, the increasing level
of  p53,  and  the  development  of  replicative  senescence  in
bovine corneal endothelial cells in culture when the number
of population doublings was increased to between 75 and 100.
This may be the reason why neither telomere length nor p53
expression of HCECs from ex vivo corneas appeared to be
different with age in the previous investigations and this study.
In its role in the cell cycle control, p53 binds to and promotes
the p21WAF1/CIP1 gene. It is known that p53 is associated with a
response to DNA damage either to inhibit cell division or to
cause apoptosis. No age-related difference could be observed
in the expression levels of p53 or p21WAF1/CIP1 in the HCECs
from ex vivo corneas.
In  the  current  study,  we  cannot  rule  out  that  organ
procurement (harvesting and preservation) may have affected
gene expression in the tissue samples although the result of
the pathological examination was normal and the survival rate
of endothelial cells was comparatively high. Tissue samples
in  vivo  from  healthy  individuals  would  be  preferable;
however,  since  this  may  complicate  the  study  design
substantially, the current approach is widely accepted [49].
Moreover,  further  investigations  with  more  cases  are
necessary to accurately define the exact type of relationship
between expression and age. p16INK4a expression can be used
as an indicator for accelerated senescence of HCECs. The
potential  value  of  senescence-related  genes  in  the
development of late endothelial failure should be focused
further. It is still unclear whether the different age-related
responses of some CDKI genes are a result of environmental
stresses  or  inherently  determined  by  the  age-related
expression  of  p16INK4a.  CDKI  genes  are  involved  in  the
negative regulation of cell cycle and suppression of HCEC
proliferation,  which  may  help  to  explore  the  methods  to
enhance the ECD of corneas ex vivo and in vivo.
In summary, p16INK4a, p21WAF1/CIP1, p27KIP1, and p53 are
all expressed in HCECs despite donor ages. We conclude from
the age-related increase in p16INK4a expression that p16INK4a
signal  pathway  might  play  a  key  role  in  the  process  of
senescence in HCECs.
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